ARS Pharmaceuticals, Inc. SPRY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$60.62M-46.7% | -$41.32M+19.2% | -$51.15M-14.0% | -$44.88M-32.2% | -$33.94M-168% | ||
| $397K-4.8% | $417K+6.6% | $391K+40.1% | $279K-0.4% | $280K+866% | ||
| $7.42M+29.4% | $5.74M+0.8% | $5.69M+5.9% | $5.37M+1.4% | $5.3M+24.3% | ||
| -$44.95M-3.4% | -$43.49M+7.6% | -$47.05M-18.8% | -$39.59M+2.8% | -$40.74M-197% | ||
| $0— | $0-100% | $197K+286% | $51K-44.0% | $91K-69.9% | ||
| $27.79M+15.2% | $24.11M— | —— | $48.57M+67.1% | $29.06M+129% | ||
| $159K-85.9% | $1.13M-98.9% | $100.05M+3,609% | $2.7M+272% | $725K-99.0% | ||
| -$17M+6.8% | -$18.24M-328% | $8.02M-31.3% | $11.68M+207% | -$10.95M— | ||
| -$44.95M-3.4% | -$43.49M+8.0% | -$47.24M-19.2% | -$39.64M+2.9% | -$40.83M-198% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ARS Pharmaceuticals, Inc. generate?
- ARS Pharmaceuticals, Inc. (SPRY) generated -$175.1M in operating cash flow over the trailing twelve months.
- What is ARS Pharmaceuticals, Inc.'s free cash flow?
- After $248.0K of capital expenditures, ARS Pharmaceuticals, Inc.'s free cash flow was -$175.3M over the trailing twelve months, down 732.7% year over year.
- Where does ARS Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from ARS Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
